Accelerating antiviral drug discovery: lessons from COVID-19
During the coronavirus disease 2019 (COVID-19) pandemic, a wave of rapid and collaborative drug discovery efforts took place in academia and industry, culminating in several therapeutics being discovered, approved and deployed in a 2-year time frame. This article summarizes the collective experience...
Հիմնական հեղինակներ: | von Delft, A, Hall, MD, Kwong, AD, Purcell, LA, Saikatendu, KS, Schmitz, U, Tallarico, JA, Lee, AA |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
Springer Nature
2023
|
Նմանատիպ նյութեր
-
Antiviral research : strategies in antiviral drug discovery /
: LaFemina, Robert L., և այլն
Հրապարակվել է: (c200) -
Successful strategies for the discovery of antiviral drugs /
: Desai, Manoj C., և այլն
Հրապարակվել է: (2013) -
Glycobiology against viruses: Antiviral drug discovery
: Zitzmann, N, և այլն
Հրապարակվել է: (2006) -
Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
: Abdulaziz L, և այլն
Հրապարակվել է: (2022-03-01) -
Antiviral drug discovery for emerging diseases and bioterrorism threats /
: Torrence, Paul F.
Հրապարակվել է: (2005)